Jeremy Kortmansky

基本信息

浏览量：0

职业迁徙

个人简介

Extensive Research Description
GI oncology

Research Interests
Gastrointestinal Diseases; Pancreatic Neoplasms; Colorectal Neoplasms

研究兴趣

论文共 27 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

A Single Arm Phase 2 Clinical Trial of YIV-906 with Neoadjuvant Concurrent Chemo-Radiation Therapy in Patients with Locally Advanced Rectal Cancer

Nipun Verma,Kimberly L. Johung,Jeremy Kortmansky, Wajih Zaheer,Jill Lacy,Michael Cecchini,Stacey Stein,Yung-Chi Cheng,Wing Lam,Shwu-Huey Liu,Vikram Reddy,Howard Hochster,Susan A. Higgins

JOURNAL OF GASTROINTESTINAL ONCOLOGY（2024）

引用0浏览0WOS引用

Pembrolizumab Plus Mfolfox7 or FOLFIRI for Microsatellite Stable/Mismatch Repair–Proficient Metastatic Colorectal Cancer: KEYNOTE-651 Cohorts B and D

Richard Kim,Mustapha Tehfe,Petr Kavan,Jorge Chaves,Jeremy S. Kortmansky,Eric X. Chen,Christopher H. Lieu,Lucas Wong,Marwan Fakih,Kristen Spencer,Qing Zhao,Raluca Predoiu,Chenxiang Li,Pierre Leconte,David Adelberg,Gabriela Chiorean

CLINICAL COLORECTAL CANCERno. 2 (2024)

引用0浏览0WOS引用

Pembrolizumab Plus Binimetinib With or Without Chemotherapy for MSS/pMMR Metastatic Colorectal Cancer: Outcomes From KEYNOTE-651 Cohorts A, C, and E

Eric X. Chen,Petr Kavan,Mustapha Tehfe,Jeremy S. Kortmansky,Michael B. Sawyer,E. Gabriela Chiorean,Christopher H. Lieu,Blase Polite,Lucas Wong,Marwan Fakih,Kristen Spencer,Jorge Chaves,Chenxiang Li,Pierre Leconte,David Adelberg,Richard Kim

CLINICAL COLORECTAL CANCERno. 2 (2024): 183-193

引用0浏览0引用

Combining Antivascular Endothelial Growth Factor and Anti-Epidermal Growth Factor Receptor Antibodies: Randomized Phase II Study of Irinotecan and Cetuximab With/without Ramucirumab in Second-Line Colorectal Cancer (ECOG-ACRIN E7208)

Howard S. Hochster,Paul Catalano,Michelle Weitz,Edith P. Mitchell,Deirdre Cohen,Peter J. O'Dwyer, Bryan A. Faller,Jeremy S. Kortmansky,Mark H. O'Hara, Sheetal M. Kricher,Jill Lacy,Heinz-Josef Lenz,Udit Verma,Al B. Benson

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTEno. 9 (2024)

引用0浏览0WOS引用

Pembrolizumab Plus Binimetinib With or Without Chemotherapy for MSS/pMMR Metastatic Colorectal Cancer: Outcomes From KEYNOTE-651 Cohorts A, C, and E

Clinical Colorectal Cancerno. 2 (2024): 183-193

引用0浏览0WOS引用

A Phase 2 Study of Savolitinib in Patients with MET Amplified Metastatic Colorectal Cancer

Jingquan Jia, Ashley Moyer,Melissa Lowe,Emily Bolch,Jeremy Kortmansky,May Cho,Heinz-Josef Lenz,Aparna Kalyan,Donna Niedzwiecki,John Strickler

crossref（2024）

引用0浏览0引用

Pembrolizumab (pembro) Plus Binimetinib (bini) with or Without Chemotherapy (chemo) for Metastatic Colorectal Cancer (mcrc): Results from KEYNOTE-651 Cohorts A, C, and E

Eric Xueyu Chen,Petr Kavan,Mustapha Tehfe,Jeremy S. Kortmansky,Michael B. Sawyer,E. Gabriela Chiorean,Christopher Hanyoung Lieu,Blase N. Polite,Lucas Wong,Marwan Fakih,Kristen Renee Spencer,Jorge Chaves,Chenxiang Li,David Carpenter,Pierre Leconte,Richard D. Kim

Journal of clinical oncology（2022）

引用0浏览0引用

Pembrolizumab (pembro) plus mFOLFOX7 or FOLFIRI for metastatic colorectal cancer (CRC) in KEYNOTE-651: Long-term follow-up of cohorts B and D

Richard D. Kim,Mustapha Tehfe,Petr Kavan,Jorge Chaves,Jeremy S. Kortmansky,Eric Xueyu Chen,Christopher Hanyoung Lieu,Lucas Wong,Marwan Fakih,Kristen Renee Spencer,Qing Zhao,Raluca Predoiu,Chenxiang Li,David Carpenter,Pierre Leconte,E. Gabriela Chiorean

JOURNAL OF CLINICAL ONCOLOGY（2022）

引用1浏览0引用

Implementing the Cancer and Aging Research Group (CARG) Tool in the Ambulatory Oncology Setting to Drive Informed Treatment Selection

Alexander Mbewe, Paula Pike, Russell Lewis,Jeremy S. Kortmansky,Anne C. Chiang, Jane Kanowitz

Journal of clinical oncology（2021）

引用1浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn

副教授

论文共 27 篇作者统计合作学者相似作者